Prospective Sexual Function Study for BPH Subjects
Status:
Completed
Trial end date:
2016-04-05
Target enrollment:
Participant gender:
Summary
This is an European double-blind, placebo controlled parallel group comparison of DUODART
(fixed dose combination of dutasteride 0.5mg and tamsulosin 0.4mg, one capsule daily) and
placebo.
PRIMARY OBJECTIVE:
To assess the change in sexual function from baseline to 1 year in sexually active men with
at least moderate BPH who are treated with DUODART, compared to men treated with placebo .